Filing Details

Accession Number:
0000950170-24-128163
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-18 19:20:03
Reporting Period:
2024-11-14
Accepted Time:
2024-11-18 19:20:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1819133 Tango Therapeutics Inc. TNGX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1873988 Mace Rothenberg C/O Tango Therapeutics, Inc.
201 Brookline Ave., Suite 901
Boston MA 02215
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-14 10,000 $3.62 21,250 No 4 P Direct
Common Stock Acquisiton 2024-11-18 10,000 $3.78 31,250 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct